• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多系统萎缩中的多巴胺能反应。

The dopaminergic response in multiple system atrophy.

作者信息

Hughes A J, Colosimo C, Kleedorfer B, Daniel S E, Lees A J

机构信息

Department of Neurology, Middlesex Hospital, London, UK.

出版信息

J Neurol Neurosurg Psychiatry. 1992 Nov;55(11):1009-13. doi: 10.1136/jnnp.55.11.1009.

DOI:10.1136/jnnp.55.11.1009
PMID:1469394
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1015283/
Abstract

Fifteen of 23 pathologically confirmed cases of multiple system atrophy (MSA) showed some initial response to levodopa and eight of these remained at least partially responsive at the time of death. Eleven developed motor oscillations, and drug-induced dyskinesias, often involving the face and jaw, were also seen in 11 cases. Acute levodopa and apomorphine challenges were administered to 11 patients with clinical MSA who were considered levodopa responsive. A short duration relatively small amplitude response with associated dyskinesias occurred in six and a further three developed dyskinesias without any motor response. Following levodopa withdrawal, a delayed deterioration occurred after three to six days in six patients, five of whom had shown no short duration motor response to the acute challenges. The occurrence of levodopa-induced dyskinesias without a concomitant motor response and delayed deterioration several days after levodopa withdrawal may be more typical of patients with MSA than Parkinson's disease.

摘要

23例经病理证实的多系统萎缩(MSA)病例中,有15例对左旋多巴有一些初始反应,其中8例在死亡时仍至少有部分反应。11例出现运动波动,11例还出现药物性异动症,常累及面部和下颌。对11例临床诊断为MSA且被认为对左旋多巴有反应的患者进行了急性左旋多巴和阿扑吗啡激发试验。6例出现持续时间短、幅度相对较小的反应并伴有异动症,另外3例出现异动症但无任何运动反应。停用左旋多巴后,6例患者在3至6天后出现延迟性病情恶化,其中5例对急性激发试验未表现出短时间的运动反应。左旋多巴诱发的异动症不伴有相应运动反应以及在停用左旋多巴几天后出现延迟性病情恶化,可能在MSA患者中比帕金森病患者更为典型。

相似文献

1
The dopaminergic response in multiple system atrophy.多系统萎缩中的多巴胺能反应。
J Neurol Neurosurg Psychiatry. 1992 Nov;55(11):1009-13. doi: 10.1136/jnnp.55.11.1009.
2
Beginning-of-dose motor deterioration following the acute administration of levodopa and apomorphine in Parkinson's disease.帕金森病患者急性服用左旋多巴和阿扑吗啡后出现的起始剂量运动功能恶化。
J Neurol Neurosurg Psychiatry. 1992 Nov;55(11):1024-6. doi: 10.1136/jnnp.55.11.1024.
3
Subcutaneous apomorphine : an evidence-based review of its use in Parkinson's disease.皮下注射阿扑吗啡:关于其在帕金森病中应用的循证综述
Drugs Aging. 2004;21(11):687-709. doi: 10.2165/00002512-200421110-00001.
4
Motor response to acute dopaminergic challenge with apomorphine and levodopa in Parkinson's disease: implications for the pathogenesis of the on-off phenomenon.帕金森病中阿扑吗啡和左旋多巴急性多巴胺能刺激的运动反应:对开关现象发病机制的启示
J Neurol Neurosurg Psychiatry. 1996 Jun;60(6):634-7. doi: 10.1136/jnnp.60.6.634.
5
Continuous subcutaneous waking day apomorphine in the long term treatment of levodopa induced interdose dyskinesias in Parkinson's disease.持续皮下注射阿扑吗啡用于帕金森病左旋多巴诱导的剂末异动症的长期治疗
J Neurol Neurosurg Psychiatry. 1998 May;64(5):573-6. doi: 10.1136/jnnp.64.5.573.
6
Motor response following repeated apomorphine administration is reduced in Parkinson's disease.帕金森病患者在重复给予阿扑吗啡后运动反应降低。
Clin Neuropharmacol. 1989 Feb;12(1):14-22. doi: 10.1097/00002826-198902000-00002.
7
Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: a prospective study using single-dose challenges.持续皮下注射阿扑吗啡治疗可改善帕金森病的运动障碍:一项采用单剂量激发试验的前瞻性研究。
Mov Disord. 2005 Feb;20(2):151-7. doi: 10.1002/mds.20276.
8
Levodopa treatment does not affect low-dose apomorphine test in patients with Parkinson's disease.左旋多巴治疗对帕金森病患者的低剂量阿扑吗啡试验无影响。
Mov Disord. 2004 Dec;19(12):1511-5. doi: 10.1002/mds.20244.
9
Comparison of motor response to apomorphine and levodopa in Parkinson's disease.帕金森病中阿扑吗啡与左旋多巴运动反应的比较。
J Neurol Neurosurg Psychiatry. 1990 Nov;53(11):1004-7. doi: 10.1136/jnnp.53.11.1004.
10
Levodopa-induced dyskinesias and continuous subcutaneous infusions of apomorphine: results of a two-year, prospective follow-up.左旋多巴诱发的运动障碍与阿扑吗啡持续皮下输注:一项为期两年的前瞻性随访结果
Mov Disord. 2002 Jan;17(1):188-91. doi: 10.1002/mds.1276.

引用本文的文献

1
Biological Function Analysis of MicroRNAs and Proteins in the Cerebrospinal Fluid of Patients with Parkinson's Disease.帕金森病患者脑脊液中微小RNA和蛋白质的生物学功能分析
Int J Mol Sci. 2024 Dec 10;25(24):13260. doi: 10.3390/ijms252413260.
2
What was first and what is next in selecting device-aided therapy in Parkinson's disease? Balancing evidence and experience.在帕金森病中选择器械辅助治疗,首先要考虑什么,接下来又该考虑什么?权衡证据与经验。
J Neural Transm (Vienna). 2024 Nov;131(11):1307-1320. doi: 10.1007/s00702-024-02782-2. Epub 2024 May 15.
3
Neuropathological features of levodopa-responsive parkinsonism in multiple system atrophy: an autopsy case report and comparative neuropathological study.多系统萎缩中左旋多巴反应性帕金森综合征的神经病理学特征:一例尸检病例报告及比较神经病理学研究
Front Neurol. 2023 Nov 14;14:1293732. doi: 10.3389/fneur.2023.1293732. eCollection 2023.
4
Determinants of cognitive impairment in multiple system atrophy: Clinical and genetic study.多系统萎缩认知障碍的决定因素:临床与遗传学研究。
PLoS One. 2022 Dec 12;17(12):e0277798. doi: 10.1371/journal.pone.0277798. eCollection 2022.
5
Multiple system atrophy.多系统萎缩
Nat Rev Dis Primers. 2022 Aug 25;8(1):56. doi: 10.1038/s41572-022-00382-6.
6
Cerebrospinal fluid levels of proenkephalin and prodynorphin are differentially altered in Huntington's and Parkinson's disease.亨廷顿病和帕金森病患者脑脊液中脑啡肽原和强啡肽原水平的改变不同。
J Neurol. 2022 Sep;269(9):5136-5143. doi: 10.1007/s00415-022-11187-8. Epub 2022 Jun 23.
7
Symptomatic Care in Multiple System Atrophy: State of the Art.多系统萎缩症的对症治疗:最新进展。
Cerebellum. 2023 Jun;22(3):433-446. doi: 10.1007/s12311-022-01411-6. Epub 2022 May 17.
8
Diagnostic and Prognostic Value of External Anal Sphincter EMG Patterns in Multiple System Atrophy.肛门外括约肌肌电图模式在多系统萎缩中的诊断和预后价值。
Mov Disord. 2022 May;37(5):1069-1074. doi: 10.1002/mds.28938. Epub 2022 Feb 4.
9
Quantitative Assessment of Motor Response to a Low Subacute Levodopa Dose in the Differential Diagnosis of Parkinsonisms at Disease Onset: Data from the BoProPark Cohort.定量评估低亚急性左旋多巴剂量对发病时帕金森病的运动反应:BoProPark 队列研究数据。
J Parkinsons Dis. 2021;11(2):811-819. doi: 10.3233/JPD-202262.
10
Is Levodopa Response a Valid Indicator of Parkinson's Disease?左旋多巴反应是否能有效指示帕金森病?
Mov Disord. 2021 Apr;36(4):948-954. doi: 10.1002/mds.28406. Epub 2020 Nov 30.

本文引用的文献

1
Alternate day levodopa therapy in parkinsonism.
Neurology. 1982 Mar;32(3):324-6. doi: 10.1212/wnl.32.3.324.
2
Weekly drug holiday in Parkinson disease.
Neurology. 1981 Nov;31(11):1460-2. doi: 10.1212/wnl.31.11.1460.
3
Early onset of the "on-off" phenomenon in children with symptomatic Parkinsonism.有症状帕金森症患儿中“开-关”现象的早发
J Neurol Neurosurg Psychiatry. 1982 Sep;45(9):823-5. doi: 10.1136/jnnp.45.9.823.
4
Levodopa-free periods ("drug holidays") in the management of parkinsonism.帕金森病治疗中的无左旋多巴期(“药物假期”)
Adv Neurol. 1983;37:33-43.
5
Dopamine metabolism in the central nervous system after discontinuation of L-dopa therapy in patients with Parkinson disease.帕金森病患者停用左旋多巴治疗后中枢神经系统中的多巴胺代谢
J Neurol Sci. 1984 Nov-Dec;66(2-3):151-63. doi: 10.1016/0022-510x(84)90003-0.
6
The pharmacology of olivopontocerebellar atrophy.橄榄体脑桥小脑萎缩的药理学
Adv Neurol. 1984;41:143-8.
7
[Striatonigral degeneration associated with olivopontocerebellar atrophy. Anatomo-clinical study of 3 cases. Nosologic discussion].
Rev Neurol (Paris). 1983;139(2):125-39.
8
L-dopa therapy of Parkinson's disease: plasma L-dopa concentration, therapeutic response, and side effects.帕金森病的左旋多巴治疗:血浆左旋多巴浓度、治疗反应及副作用。
Mayo Clin Proc. 1971 Apr;46(4):231-9.
9
Striatonigral degeneration response to levodopa therapy.纹状体黑质变性对左旋多巴治疗的反应。
J Neurol Sci. 1972 Jul;16(3):331-41. doi: 10.1016/0022-510x(72)90196-7.
10
Striatonigral degeneration, Alzheimer's disease, and inflammatory changes.
Neurology. 1973 Nov;23(11):1211-6. doi: 10.1212/wnl.23.11.1211.